Advertisement

Perfusion brain SPECT and Alzheimer disease.

04:53 EDT 25th May 2013 | BioPortfolio

Summary of "Perfusion brain SPECT and Alzheimer disease."

Alzheimer Disease (AD) is the most frequent cause of degenerative dementia. There is an asymptomatic phase of the disease. Brain single photon computed tomography (SPECT) is a simple way to investigate the cerebral blood flow. Alzheimer's disease is characterized by hypoperfusion in the medial temporal, associative posterior parietal cortex and frontal cortex. Brain SPECT could also have an interest in the early detection of amnesic mild cognitive impairment (MCI) patients with a high risk of conversion to AD. Indeed, the hypoperfusion of the associative parietal cortex in MCI patients is considered predictive of a rapid conversion to AD. Different scintigraphic patterns of neurodegenerative dementias could be used for their differential diagnosis.

Affiliation

AP-HP, hôpital Hôtel-Dieu, service de médecine nucléaire, 75004 Paris, France.

Journal Details

This article was published in the following journal.

Name: Presse medicale (Paris, France : 1983)
ISSN: 0755-4982
Pages:

Links

Medical and Biotech [MESH] Definitions

Aphasia, Primary Progressive

A progressive form of dementia characterized by the global loss of language abilities and initial preservation of other cognitive functions. Fluent and nonfluent subtypes have been described. Eventually a pattern of global cognitive dysfunction, similar to ALZHEIMER DISEASE, emerges. Pathologically, there are no Alzheimer or PICK DISEASE like changes, however, spongiform changes of cortical layers II and III are present in the TEMPORAL LOBE and FRONTAL LOBE. (From Brain 1998 Jan;121(Pt 1):115-26)

Neurofibrillary Tangles

Abnormal structures located in various parts of the brain and composed of dense arrays of paired helical filaments (neurofilaments and microtubules). These double helical stacks of transverse subunits are twisted into left-handed ribbon-like filaments that likely incorporate the following proteins: (1) the intermediate filaments: medium- and high-molecular-weight neurofilaments; (2) the microtubule-associated proteins map-2 and tau; (3) actin; and (4) UBIQUITINS. As one of the hallmarks of ALZHEIMER DISEASE, the neurofibrillary tangles eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus, brain stem, and diencephalon. The number of these tangles, as seen in post mortem histology, correlates with the degree of dementia during life. Some studies suggest that tangle antigens leak into the systemic circulation both in the course of normal aging and in cases of Alzheimer disease.

Neuropil Threads

Abnormal structures located chiefly in distal dendrites and, along with NEUROFIBRILLARY TANGLES and SENILE PLAQUES, constitute the three morphological hallmarks of ALZHEIMER DISEASE. Neuropil threads are made up of straight and paired helical filaments which consist of abnormally phosphorylated microtubule-associated tau proteins. It has been suggested that the threads have a major role in the cognitive impairment seen in Alzheimer disease.

Alzheimer Vaccines

Vaccines or candidate vaccines used to prevent or treat ALZHEIMER DISEASE.

Tacrine

A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.

PubMed Articles [ 17183 Associated PubMed Articles listed on BioPortfolio]

Distinct patterns of medial temporal impairment in degenerative dementia: a brain SPECT perfusion study in Alzheimer's disease and frontotemporal dementia.

PURPOSE: Medial temporal impairment can be detected clinically and by morphological imaging during Alzheimer's disease (AD), but the existence of a functional impairment in this area seems to be less...

Impact of CT attenuation correction by SPECT/CT in brain perfusion images.

PURPOSE: The aim of this study was to elucidate the regional differences between brain perfusion single photon emission computed tomography (SPECT) images reconstructed with a un...

Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal)synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT.

OBJECTIVE: The reinforcement of the anterior cerebral artery (ACA) territory perfusion is important for the future intellectual functioning of pediatric moyamoya disease (MMD) pa...

Kana Pick-out Test and brain perfusion imaging in Alzheimer's disease.

ABSTRACTBackground: The Kana Pick-out Test (KPT), which was developed in Japan, is suitable for evaluating frontal lobe function and screening for mild dementia. However, the neural substrates involve...

Initial Mini-Mental State and Cerebral Perfusion in Alzheimer's Disease.

PURPOSE: The relationship between the initial mini-mental state examination (MMSE) score and cerebral perfusion was evaluated in patients with Alzheimer's disease (AD)....

Clinical Trials [ 3535 Associated Clinical Trials listed on BioPortfolio]

Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

The main objectives of this proposal are as follows: To assess the dynamic uptake and washout of 123-I MNI-330, a potential imaging biomarker for β-amyloid burden in brain, using single...

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

The main objectives of this proposal are as follows: To assess the dynamic uptake and washout of 123-I AV51, a potential imaging biomarker for β-amyloid burden in brain, using single pho...

Evaluation of [123I] AV151 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Purpose: The main objectives of this proposal are as follows: To assess the dynamic uptake and washout of 123-I AV151, a potential imaging biomarker for β-amyloid burden in brain,...

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid Deposition in the Brain of Patients With Alzheimer's Disease

This research is designed to obtain efficacy and safety information for 123-I IMPY as an imaging biomarker for Alzheimer's disease (AD). The distribution of this agent will be measured by...

Evaluation of [123I] AV94 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

The main objectives of this proposal are as follows: To assess the dynamic uptake and washout of 123-I AV94, a potential imaging biomarker for β-amyloid burden in brain, using single pho...

Search BioPortfolio:
Advertisement
Advertisement